These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 22013123)

  • 1. A neutralizing human monoclonal antibody protects african green monkeys from hendra virus challenge.
    Bossart KN; Geisbert TW; Feldmann H; Zhu Z; Feldmann F; Geisbert JB; Yan L; Feng YR; Brining D; Scott D; Wang Y; Dimitrov AS; Callison J; Chan YP; Hickey AC; Dimitrov DS; Broder CC; Rockx B
    Sci Transl Med; 2011 Oct; 3(105):105ra103. PubMed ID: 22013123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic treatment of Nipah virus infection in nonhuman primates with a neutralizing human monoclonal antibody.
    Geisbert TW; Mire CE; Geisbert JB; Chan YP; Agans KN; Feldmann F; Fenton KA; Zhu Z; Dimitrov DS; Scott DP; Bossart KN; Feldmann H; Broder CC
    Sci Transl Med; 2014 Jun; 6(242):242ra82. PubMed ID: 24964990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant Hendra virus G glycoprotein subunit vaccine protects nonhuman primates against Hendra virus challenge.
    Mire CE; Geisbert JB; Agans KN; Feng YR; Fenton KA; Bossart KN; Yan L; Chan YP; Broder CC; Geisbert TW
    J Virol; 2014 May; 88(9):4624-31. PubMed ID: 24522928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatment.
    Rockx B; Bossart KN; Feldmann F; Geisbert JB; Hickey AC; Brining D; Callison J; Safronetz D; Marzi A; Kercher L; Long D; Broder CC; Feldmann H; Geisbert TW
    J Virol; 2010 Oct; 84(19):9831-9. PubMed ID: 20660198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Cross-Reactive Humanized Monoclonal Antibody Targeting Fusion Glycoprotein Function Protects Ferrets Against Lethal Nipah Virus and Hendra Virus Infection.
    Mire CE; Chan YP; Borisevich V; Cross RW; Yan L; Agans KN; Dang HV; Veesler D; Fenton KA; Geisbert TW; Broder CC
    J Infect Dis; 2020 May; 221(Suppl 4):S471-S479. PubMed ID: 31686101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the Hendra virus attachment G glycoprotein bound to a potent cross-reactive neutralizing human monoclonal antibody.
    Xu K; Rockx B; Xie Y; DeBuysscher BL; Fusco DL; Zhu Z; Chan YP; Xu Y; Luu T; Cer RZ; Feldmann H; Mokashi V; Dimitrov DS; Bishop-Lilly KA; Broder CC; Nikolov DB
    PLoS Pathog; 2013; 9(10):e1003684. PubMed ID: 24130486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic administration of a cross-reactive mAb targeting the fusion glycoprotein of Nipah virus protects nonhuman primates.
    Zeitlin L; Cross RW; Woolsey C; West BR; Borisevich V; Agans KN; Prasad AN; Deer DJ; Stuart L; McCavitt-Malvido M; Kim DH; Pettitt J; Crowe JE; Whaley KJ; Veesler D; Dimitrov A; Abelson DM; Geisbert TW; Broder CC
    Sci Transl Med; 2024 Apr; 16(741):eadl2055. PubMed ID: 38569014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptionally potent cross-reactive neutralization of Nipah and Hendra viruses by a human monoclonal antibody.
    Zhu Z; Bossart KN; Bishop KA; Crameri G; Dimitrov AS; McEachern JA; Feng Y; Middleton D; Wang LF; Broder CC; Dimitrov DS
    J Infect Dis; 2008 Mar; 197(6):846-53. PubMed ID: 18271743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutralizing human monoclonal antibody protects against lethal disease in a new ferret model of acute nipah virus infection.
    Bossart KN; Zhu Z; Middleton D; Klippel J; Crameri G; Bingham J; McEachern JA; Green D; Hancock TJ; Chan YP; Hickey AC; Dimitrov DS; Wang LF; Broder CC
    PLoS Pathog; 2009 Oct; 5(10):e1000642. PubMed ID: 19888339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance of Cynomolgus Monkeys to Nipah and Hendra Virus Disease Is Associated With Cell-Mediated and Humoral Immunity.
    Prasad AN; Woolsey C; Geisbert JB; Agans KN; Borisevich V; Deer DJ; Mire CE; Cross RW; Fenton KA; Broder CC; Geisbert TW
    J Infect Dis; 2020 May; 221(Suppl 4):S436-S447. PubMed ID: 32022850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A recombinant Hendra virus G glycoprotein-based subunit vaccine protects ferrets from lethal Hendra virus challenge.
    Pallister J; Middleton D; Wang LF; Klein R; Haining J; Robinson R; Yamada M; White J; Payne J; Feng YR; Chan YP; Broder CC
    Vaccine; 2011 Aug; 29(34):5623-30. PubMed ID: 21689706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute Hendra virus infection: Analysis of the pathogenesis and passive antibody protection in the hamster model.
    Guillaume V; Wong KT; Looi RY; Georges-Courbot MC; Barrot L; Buckland R; Wild TF; Horvat B
    Virology; 2009 May; 387(2):459-65. PubMed ID: 19328514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hendra virus and Nipah virus animal vaccines.
    Broder CC; Weir DL; Reid PA
    Vaccine; 2016 Jun; 34(30):3525-34. PubMed ID: 27154393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization and diagnostic evaluation of monoclonal antibody-based blocking ELISA formats for detection of neutralizing antibodies to Hendra virus in mammalian sera.
    Di Rubbo A; McNabb L; Klein R; White JR; Colling A; Dimitrov DS; Broder CC; Middleton D; Lunt RA
    J Virol Methods; 2019 Dec; 274():113731. PubMed ID: 31513861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challenge.
    Bossart KN; Rockx B; Feldmann F; Brining D; Scott D; LaCasse R; Geisbert JB; Feng YR; Chan YP; Hickey AC; Broder CC; Feldmann H; Geisbert TW
    Sci Transl Med; 2012 Aug; 4(146):146ra107. PubMed ID: 22875827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antibody against the F glycoprotein inhibits Nipah and Hendra virus infections.
    Dang HV; Chan YP; Park YJ; Snijder J; Da Silva SC; Vu B; Yan L; Feng YR; Rockx B; Geisbert TW; Mire CE; Broder CC; Veesler D
    Nat Struct Mol Biol; 2019 Oct; 26(10):980-987. PubMed ID: 31570878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental Hendra virus infection of dogs: virus replication, shedding and potential for transmission.
    Middleton DJ; Riddell S; Klein R; Arkinstall R; Haining J; Frazer L; Mottley C; Evans R; Johnson D; Pallister J
    Aust Vet J; 2017 Jan; 95(1-2):10-18. PubMed ID: 28124415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type I interferon signaling protects mice from lethal henipavirus infection.
    Dhondt KP; Mathieu C; Chalons M; Reynaud JM; Vallve A; Raoul H; Horvat B
    J Infect Dis; 2013 Jan; 207(1):142-51. PubMed ID: 23089589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent neutralization of Hendra and Nipah viruses by human monoclonal antibodies.
    Zhu Z; Dimitrov AS; Bossart KN; Crameri G; Bishop KA; Choudhry V; Mungall BA; Feng YR; Choudhary A; Zhang MY; Feng Y; Wang LF; Xiao X; Eaton BT; Broder CC; Dimitrov DS
    J Virol; 2006 Jan; 80(2):891-9. PubMed ID: 16378991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.